Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	76,855	118,777	113,768	154,649	139,497	457,391
Market Cap Growth	-29.63%	4.40%	-26.43%	10.86%	-69.50%	-47.38%
Enterprise Value	-9,899	13,827	3,162	16,479	-29,937	400,389
Last Close Price	990.00	1530.00	1425.00	1818.00	1655.00	9150.00
PS Ratio	1.13	1.75	1.47	2.03	5.24	19.91
PB Ratio	0.55	0.86	0.71	0.80	0.69	6.13
P/TBV Ratio	0.57	0.89	0.73	0.82	0.70	6.73
EV/Sales Ratio	-	0.20	0.04	0.22	-	17.43
Debt / Equity Ratio	0.04	0.04	0.03	0.03	0.19	0.70
Net Debt / Equity Ratio	-0.63	-0.63	-0.69	-0.68	-0.77	-0.57
Net Debt / EBITDA Ratio	5.81	5.81	8.69	11.74	12.64	2.29
Net Debt / FCF Ratio	7.47	7.47	124.97	10.53	6.96	1.75
Asset Turnover	0.41	0.41	0.39	0.33	0.14	0.18
Inventory Turnover	5.37	5.37	5.40	5.80	2.67	2.59
Quick Ratio	11.79	11.79	11.04	10.63	4.79	1.87
Current Ratio	14.06	14.06	13.03	12.33	5.21	2.05
Return on Equity (ROE)	-12.05%	-12.05%	-12.40%	-4.74%	-18.16%	-37.87%
Return on Assets (ROA)	-6.91%	-6.91%	-5.21%	-4.01%	-4.81%	-10.10%
Return on Capital Employed (ROCE)	-13.00%	-13.00%	-9.60%	-7.50%	-7.10%	-26.10%
Earnings Yield	-23.59%	-15.27%	-19.43%	-6.03%	-17.99%	-6.09%
FCF Yield	-15.32%	-9.91%	-0.79%	-8.09%	-15.97%	-5.34%
Buyback Yield / Dilution	5.36%	5.36%	3.60%	-7.75%	-56.10%	-3.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.